Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 38, 999-1002, April 1, 1978]
© 1978 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roebuck, B. D.
Right arrow Articles by Wogan, G. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roebuck, B. D.
Right arrow Articles by Wogan, G. N.

In Vitro Metabolism of Aflatoxin B2 by Animal and Human Liver1

Bill D. Roebuck2, Wayne G. Siegel3 and Gerald N. Wogan4

Department of Nutrition and Food Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139

The metabolism of aflatoxin B2 by postmitochondrial supernatant ractions of duck, rat, mouse, and human livers was studied in an in vitro system. Duck liver had a much higher level of activity than had tissues from other species. Postmitochondrial supernatant equivalent to 0.2 g whole liver metabolized 40 to 80% of the initial substrate in 30 min, compared to < 6% for the other specles. Among several metabolites formed by duck liver, aflatoxin B1 was produced in amounts equivalent to 2 to 8% of the initial substrate, and metabolites having chromatographic properties postulated for aflatoxicols 1 and 2 and aflatoxins M1 and M2 were also formed in small amounts. In contrast, rat, mouse, and human liver preparations produced no detectable aflatoxin B1 and only small amounts of compounds thought to be aflatoxins Q2 and P2. The greater susceptibility of duck liver to the toxicity of aflatoxin B2 may be attributable to its ability to form aflatoxin B1, which could then be activated through further metabolism.

1 Financial support was provided by NIH Grants 5 PO1 ES 00597 and 5 TO1 ES 00056 and Contract NO1 CP 43265. Preliminary accounts of this work were presented at the 66th Meeting of the American Association for Cancer Research, Inc., May 7 to 11, 1975, San Diego, Calif. (10).

2 Present address: Department of Pathology, Dartmouth Medical School, Hanover, N. H. 03755.

3 Present address: University of California at San Diego Medical School, San Diego, Calif. 92115.

4 To whom requests for reprints should be addressed, at Massachusetts Institute of Technology, Room 56–215, Cambridge, Mass. 02139.

Received 9/12/77. Accepted 1/13/78.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1978 by the American Association for Cancer Research.